Short- and Long-Term Reliability of the 6-Minute Walk Test in People With Idiopathic Pulmonary Fibrosis

References

1. 1.↵
   1. Raghu G,
   2. Collard HR,
   3. Egan JJ,
   4. Martinez FJ,
   5. Behr J,
   6. Brown KK,
   7. et al

   . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183(6):788–824.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Swigris JJ,
   2. Gould MK,
   3. Wilson SR

   . Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 2005;127(1):284–294.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Nishiyama O,
   2. Taniguchi H,
   3. Kondoh Y,
   4. Kimura T,
   5. Ogawa T,
   6. Watanabe F,
   7. Nishimura K

   . Health-related quality of life in patients with idiopathic pulmonary fibrosis: what is the main contributing factor? Respir Med 2005;99(4):408–414.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Holland AE,
   2. Spruit MA,
   3. Troosters T,
   4. Puhan MA,
   5. Pepin V,
   6. Saey D,
   7. et al

   . An official European Respiratory Society/American Thoracic Society Technical Standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44(6):1428–1446.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. du Bois RM,
   2. Weycker D,
   3. Albera C,
   4. Bradford WZ,
   5. Costabel U,
   6. Kartashov A,
   7. et al

   . Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011;183(9):1231–1237.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.
   1. Hallstrand TS,
   2. Boitano LJ,
   3. Johnson WC,
   4. Spada CA,
   5. Hayes JG,
   6. Raghu G

   . The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005;25(1):96–103.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Caminati A,
   2. Bianchi A,
   3. Cassandro R,
   4. Mirenda MR,
   5. Harari S

   . Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med 2009;103(1):117–123.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Lederer DJ,
   2. Arcasoy SM,
   3. Wilt JS,
   4. D'Ovidio F,
   5. Sonett JR,
   6. Kawut SM

   . Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174(6):659–664.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. King TE Jr.,
   2. Behr J,
   3. Brown KK,
   4. du Bois RM,
   5. Lancaster L,
   6. de Andrade JA,
   7. et al

   . BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008;177(1):75–81.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Noble PW,
    2. Albera C,
    3. Bradford WZ,
    4. Costabel U,
    5. Glassberg MK,
    6. Kardatzke D,
    7. et al

    . Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011;377(9779):1760–1769.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Holland AE,
    2. Hill CJ,
    3. Conron M,
    4. Munro P,
    5. McDonald CF

    . Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008;63(6):549–554.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Kozu R,
    2. Jenkins S,
    3. Senjyu H

    . Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2011;16(8):1196–1202.

    OpenUrlPubMed
13. 13.↵
    1. Nishiyama O,
    2. Kondoh Y,
    3. Kimura T,
    4. Kato K,
    5. Kataoka K,
    6. Ogawa T,
    7. et al

    . Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008;13(3):394–399.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Eaton T,
    2. Young P,
    3. Milne D,
    4. Wells AU

    . Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171(10):1150–1157.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Kozu R,
    2. Jenkins S,
    3. Senjyu H,
    4. Mukae H,
    5. Sakamoto N,
    6. Kohno S

    . Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respirology 2010;15(4):706–713.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Hernandes NA,
    2. Wouters EF,
    3. Meijer K,
    4. Annegarn J,
    5. Pitta F,
    6. Spruit MA

    . Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J 2011;38(2):261–267.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Jenkins S,
    2. Cecins NM

    . Six-minute walk test in pulmonary rehabilitation: do all patients need a practice test? Respirology 2010;15(8):1192–1196.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Spencer LM,
    2. Alison JA,
    3. McKeough ZJ

    . Six-minute walk test as an outcome measure: are two six-minute walk tests necessary immediately after pulmonary rehabilitation and at three-month follow-up? Am J Phys Med Rehabil 2008;87(3):224–228.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Dowman L,
    2. Hill CJ,
    3. Holland AE

    . Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014;(10):CD006322.
20. 20.↵
    1. Brown AW,
    2. Nathan SD

    . The value and application of the 6-minute-walk test in idiopathic pulmonary fibrosis. Ann Am Thorac Soc 2018;15(1):3–10.

    OpenUrl
21. 21.↵
    1. Tomioka H,
    2. Imanaka K,
    3. Hashimoto K,
    4. Iwasaki H

    . Health-related quality of life in patients with idiopathic pulmonary fibrosis–cross-sectional and longitudinal study. Intern Med 2007;46(18):1533–1542.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Collard HR,
    2. King TE Jr.,
    3. Bartelson BB,
    4. Vourlekis JS,
    5. Schwarz MI,
    6. Brown KK

    . Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168(5):538–542.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Flaherty KR,
    2. Andrei AC,
    3. Murray S,
    4. Fraley C,
    5. Colby TV,
    6. Travis WD,
    7. et al

    . Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006;174(7):803–809.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Holland AE,
    2. Hill CJ,
    3. Glaspole I,
    4. Goh N,
    5. Dowman L,
    6. McDonald CF

    . Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease. Respir Med 2013;107(7):1066–1072.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Lettieri CJ,
    2. Nathan SD,
    3. Browning RF,
    4. Barnett SD,
    5. Ahmad S,
    6. Shorr AF

    . The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med 2006;100(10):1734–1741.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Lama VN,
    2. Flaherty KR,
    3. Toews GB,
    4. Colby TV,
    5. Travis WD,
    6. Long Q,
    7. et al

    . Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168(9):1084–1090.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Dowman LM,
    2. McDonald CF,
    3. Hill CJ,
    4. Lee AL,
    5. Barker K,
    6. Glaspole I,
    7. et al

    . The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax 2017;72(7):610–619.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Macintyre N,
    2. Crapo RO,
    3. Viegi G,
    4. Johnson DC,
    5. van der Grinten CP,
    6. Brusasco V,
    7. et al

    . Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720–735.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Knudson RJ,
    2. Slatin RC,
    3. Lebowitz MD,
    4. Burrows B

    . The maximal expiratory-flow volume curve: normal standards, variability and effects of age. Am Rev Respir Dis 1976;113(5):587–600.

    OpenUrlPubMedWeb of Science
31. 31.↵
    1. Roca J,
    2. Rodriguez-Roisin R,
    3. Cobo E,
    4. Burgos F,
    5. Perez J,
    6. Clausen JL

    . Single-breath carbon monoide diffusing capacity prediction equations from a Mediterranean population. Am Rev Respir Dis 1990;141(4 Pt 1):1026–1032.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.↵
    1. Fiore C,
    2. Lee A,
    3. McDonald C,
    4. Hill C,
    5. Holland A

    . Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test? Chron Respir Dis 2011;8(3):181–184.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Borg G

    . Psycho physical bases of perceived exertion. Med Sci Sports Exerc 1982;14(5):377–381.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Portney LG,
    2. Watkins MP

    . Foundations of clinical research: applications to practice. New Jersey: Prentice Hall; 2000:585–619.
35. 35.↵
    1. Bland JM,
    2. Altman DG

    . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;327(8476):307–310.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Jenkins S,
    2. Cecins N,
    3. Camarri B,
    4. Williams C,
    5. Thompson P,
    6. Eastwood P

    . Regression equations to predict 6-minute walk distance in middle-aged and elderly adults. Physiother Theory Pract 2009;25(7):516–522.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Eiser N,
    2. Willsher D,
    3. Doré CJ

    . Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients. Respir Med 2003;97(4):407–414.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Stevens D,
    2. Elpern E,
    3. Sharma K,
    4. Szidon P,
    5. Ankin M,
    6. Kesten S

    . Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med 1999;160(5 Pt 1):1540–1543.

    OpenUrlCrossRefPubMedWeb of Science
39. 39.↵
    1. Holland AE,
    2. Dowman L,
    3. Fiore J Jr.,
    4. Brazzale D,
    5. Hill CJ,
    6. McDonald CF

    . Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test. BMC Pulm Med 2014;14:136.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Swigris JJ,
    2. Swick J,
    3. Wamboldt FS,
    4. Sprunger D,
    5. du Bois R,
    6. Fischer A,
    7. et al

    . Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009;136(3):841–848.

    OpenUrlCrossRefPubMedWeb of Science